Literature DB >> 2751721

An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia.

F A Bailey1, M Lilly, L F Bertoli, G V Ball.   

Abstract

A non-complement-dependent antibody that inhibits bone marrow proliferation in vitro was detected in the serum of a patient with systemic lupus erythematosus and aplastic anemia. The patient recovered from the aplastic anemia following treatment with corticosteroids and plasmapheresis. The antibody could no longer be detected after this recovery. This case demonstrates that a rare, but potentially lethal, complication of systemic lupus erythematosus is aplastic anemia due to an autoantibody. Results of the experiments suggest a mechanism for, and treatment of, similar cases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751721

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Drug-induced myelosuppression : diagnosis and management.

Authors:  Peter J Carey
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin.

Authors:  M Voulgarelis; S I Kokori; J P Ioannidis; A G Tzioufas; D Kyriaki; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 3.  The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.

Authors:  Gholam-Hossein Alishiri; Amin Saburi; Noushin Bayat; Ali-Reza Saadat; Ehsan Saburi
Journal:  Clin Rheumatol       Date:  2011-10-21       Impact factor: 2.980

Review 4.  Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.

Authors:  Erik Anderson; Bhakti Shah; Anne Davidson; Richard Furie
Journal:  Semin Arthritis Rheum       Date:  2017-12-08       Impact factor: 5.532

5.  A case of Sjögren's syndrome complicating immune-mediated aplastic anaemia.

Authors:  M Satoh; H Yamagata; F Watanabe; Y Matsushita; S Nakayama; M Murakami; J Matsuyama; S Oshima; M Akizuki
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

Review 6.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

7.  Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias.

Authors:  R M Pereira; E R Velloso; Y Menezes; S Gualandro; J Vassalo; N H Yoshinari
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

8.  Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE).

Authors:  H Liu; K Ozaki; Y Matsuzaki; M Abe; M Kosaka; S Saito
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 9.  Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review.

Authors:  Émilie Chalayer; Martine Ffrench; Pascal Cathébras
Journal:  Rheumatol Int       Date:  2014-10-30       Impact factor: 3.580

10.  The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.

Authors:  John V Asimakopoulos; Evangelos Terpos; Loula Papageorgiou; Olga Kampouropoulou; Dimitris Christoulas; Anastasios Giakoumis; Michael Samarkos; George Vaiopoulos; Konstantinos Konstantopoulos; Maria K Angelopoulou; Theodoros P Vassilakopoulos; John Meletis
Journal:  Med Sci Monit       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.